Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above- The New Indian Express
Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to government The data shared with Indian authorities include real-world evidence of BNT162b2 vaccine effectiveness and safety from national immunization programmes. Share Via Email | A+A A- By PTI NEW DELHI: Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown "high effectiveness" against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for e...